Skip to main content
. 2024 Nov 23;15:20406207241300809. doi: 10.1177/20406207241300809

Figure 4.

Figure 4.

The titre of FVIII-specific IgG1–IgG4 during the ReITIrate study period for individual subjects (OD): (a) Subject that obtained a negative inhibitor titre at week 60; (b, c) Subjects deemed as partial success according to protocol definitions; (d) Subject who achieved complete ITI success.

The y-axis scale differs between subjects. *Subjects that completed ITI and the ReITIrate study.

FVIII, factor VIII; Ig, immunoglobulin; ITI, immune tolerance induction; OD, optical density.